A senate committee must act next: committee consideration.
Legislative Progress
Senate
House
President
Law
Could go either way
This bill has strong bipartisan support from two well known senators, but it only requires a study rather than immediate policy changes.
Key Points
This bill asks the government to study how to make more drug ingredients in the United States. Currently, many of the raw materials used to make medicine come from foreign countries that might not always be friendly to the U.S.
The Centers for Medicare and Medicaid Services would have one year to write a report for Congress. This report would look at ways to use government spending to support local factories and protect them from unfair competition from overseas.
The report might suggest setting minimum prices for American made ingredients so they can compete with cheaper foreign products. It could also recommend that the government prioritize buying medicine made with U.S. materials whenever possible.
The bill requires the government to find out where our drug ingredients are actually coming from. Right now, there are gaps in the data about who owns the companies that make these materials and where they are located.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
2 milestones2 actions
Aug 6, 2026Senate
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Aug 6, 2026
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Source Information
Document Type
Congressional Bill
Official Title
American Pharmaceutical Security Act
Bill NumberS 5297
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Finance.